Literature DB >> 19891557

Host genetic determinants of spontaneous hepatitis C clearance.

Andri Rauch1, Silvana Gaudieri, Chloe Thio, Pierre-Yves Bochud.   

Abstract

Acute infection with the hepatitis C virus (HCV) induces a wide range of innate and adaptive immune responses. A total of 20-50% of acutely HCV-infected individuals permanently control the virus, referred to as 'spontaneous hepatitis C clearance', while the infection progresses to chronic hepatitis C in the majority of cases. Numerous studies have examined host genetic determinants of hepatitis C infection outcome and revealed the influence of genetic polymorphisms of human leukocyte antigens, killer immunoglobulin-like receptors, chemokines, interleukins and interferon-stimulated genes on spontaneous hepatitis C clearance. However, most genetic associations were not confirmed in independent cohorts, revealed opposing results in diverse populations or were limited by varying definitions of hepatitis C outcomes or small sample size. Coordinated efforts are needed in the search for key genetic determinants of spontaneous hepatitis C clearance that include well-conducted candidate genetic and genome-wide association studies, direct sequencing and follow-up functional studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891557     DOI: 10.2217/pgs.09.121

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  37 in total

Review 1.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

Review 3.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

4.  Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Authors:  Arthur Y Kim; Thomas Kuntzen; Joerg Timm; Brian E Nolan; Melanie A Baca; Laura L Reyor; Andrew C Berical; Andrea J Feller; Kristin L Johnson; Julian Schulze zur Wiesch; Gregory K Robbins; Raymond T Chung; Bruce D Walker; Mary Carrington; Todd M Allen; Georg M Lauer
Journal:  Gastroenterology       Date:  2010-09-24       Impact factor: 22.682

5.  Functional polymorphisms of TLR8 are associated with hepatitis C virus infection.

Authors:  Chiou-Huey Wang; Hock-Liew Eng; Kuei-Hsiang Lin; Hsiang-Chun Liu; Cheng-Hsien Chang; Tsun-Mei Lin
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

6.  Innate and adaptive immunity shape circulating HCV strains.

Authors:  Silvana Gaudieri; Michaela Lucas
Journal:  Nat Genet       Date:  2017-04-26       Impact factor: 38.330

7.  The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.

Authors:  Jamal Sarvari; Afagh Moattari; Neda Pirbonyeh; Maryam Moini; Seyed Younes Hosseini
Journal:  J Clin Lab Anal       Date:  2015-05-20       Impact factor: 2.352

Review 8.  Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Authors:  Babs E Verstrepen; André Boonstra; Gerrit Koopman
Journal:  World J Hepatol       Date:  2015-01-27

9.  Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.

Authors:  R Carapito; H Poustchi; M Kwemou; M Untrau; A H Sharifi; S Merat; A Haj-Sheykholeslami; H Jabbari; S Esmaili; S Michel; J Toussaint; M Le Gentil; A Ansari-Moghaddam; M Radosavljevic; A Etemadi; P Georgel; R Malekzadeh; S Bahram
Journal:  Genes Immun       Date:  2015-09-17       Impact factor: 2.676

10.  Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.

Authors:  Col Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2011-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.